The genomic, transcriptomic, and immunologic landscape of TEM8 (ANTXR1) in small-cell lung cancer (SCLC).

被引：0
|
作者：
Kareff, Samuel A.
Krause, Harris Benjamin
Elliott, Andrew
Lopes, Gilberto
Lou, Emil
Soares, Heloisa P.
Oberley, Matthew James
Chauhan, Aman
机构：
[1] Univ Miami, Sylvester Comprehens Canc Ctr, Jackson Mem Hosp, Miami, FL USA
[2] Caris Life Sci, Irving, TX USA
[3] Caris Life Sci, Phoenix, AZ USA
[4] Univ Miami, Miami, FL USA
[5] Univ Minnesota, Minneapolis, MN USA
[6] Univ Utah Hlth, Hunstman Canc Hosp, Salt Lake City, UT USA
[7] Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3128
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Genomic landscape of small cell carcinoma of the breast (SCCB) contrasted to small cell carcinoma of the lung (SCLC).
    McCullar, Brennan
    Pandey, Manjari
    Hare, Felicia
    Patel, Kruti
    Stein, Matthew
    Crawley, Melissa
    Yaghmour, George
    Feldman, Rebecca
    Martin, Michael Gary
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [22] BETA-1 INTEGRIN EXPRESSION BY SMALL-CELL LUNG-CANCER (SCLC) CELLS
    FELDMAN, LE
    NATALE, RB
    SHIN, KC
    TODD, RF
    CLINICAL RESEARCH, 1990, 38 (02): : A311 - A311
  • [23] TEM8/ANTXR1-Specific CAR T Cells as a Targeted Therapy for Triple-Negative Breast Cancer
    Byrd, Tiara T.
    Fousek, Kristen
    Pignata, Antonella
    Szot, Christopher
    Samaha, Heba
    Seaman, Steven
    Dobrolecki, Lacey
    Salsman, Vita S.
    Oo, Htoo Zarni
    Bielamowicz, Kevin
    Landi, Daniel
    Rainusso, Nino
    Hicks, John
    Powell, Suzanne
    Baker, Matthew L.
    Wels, Winfried S.
    Koch, Joachim
    Sorensen, Poul H.
    Deneen, Benjamin
    Ellis, Matthew J.
    Lewis, Michael T.
    Hegde, Meenakshi
    Fletcher, Bradley S.
    St Croix, Brad
    Ahmed, Nabil
    CANCER RESEARCH, 2018, 78 (02) : 489 - 500
  • [24] First-line chemotherapy in metastatic small-cell lung cancer (SCLC)
    Wolf, M
    Tebbe, S
    Fink, T
    LUNG CANCER, 2004, 45 : S223 - S234
  • [25] IMMUNOHISTOCHEMICAL PHENOTYPE RELATED TO PROGNOSIS IN SMALL-CELL LUNG-CANCER (SCLC)
    MORITTU, L
    SHEPPARD, MN
    BOBROW, LG
    SOUHAMI, RL
    BRITISH JOURNAL OF CANCER, 1987, 56 (02) : 231 - 231
  • [26] COMBINED-MODALITY TREATMENT IN SMALL-CELL LUNG-CANCER (SCLC)
    GREGOR, A
    EUROPEAN JOURNAL OF CANCER, 1995, 31A (05) : 816 - 818
  • [27] SEOM clinical guidelines for the treatment of small-cell lung cancer (SCLC) (2019)
    Domine, M.
    Moran, T.
    Isla, D.
    Marti, J. L.
    Sullivan, I.
    Provencio, M.
    Olmedo, M. E.
    Ponce, S.
    Blasco, A.
    Cobo, M.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2020, 22 (02): : 245 - 255
  • [28] THE ROLE OF MAINTENANCE CHEMOTHERAPY(CT) IN SMALL-CELL LUNG CANCER(SCLC) TREATMENT
    DEMARINIS, F
    MACCONE, C
    PALLETTA, G
    EUROPEAN JOURNAL OF RESPIRATORY DISEASES, 1986, 69 : A50 - A50
  • [29] SEOM clinical guidelines for the treatment of small-cell lung cancer (SCLC) (2019)
    M. Dómine
    T. Moran
    D. Isla
    J. L. Martí
    I. Sullivan
    M. Provencio
    M. E. Olmedo
    S. Ponce
    A. Blasco
    M. Cobo
    Clinical and Translational Oncology, 2020, 22 : 245 - 255
  • [30] THE CYTOKERATINS OF SMALL-CELL LUNG-CANCER (SCLC) - EVIDENCE FOR EPITHELIAL ORIGIN
    ELIAS, AD
    COHEN, BF
    WEINBERG, K
    BERNAL, SD
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 43 - 43
12345